Baidu
map

栗占国教授被聘为《临床免疫病》(Clinical Rheumatology)杂志副主编

2014-01-28 bdfs.org bdfs.org

日前,北京大学人民医院栗占国教授被聘Clinical Rheumatology杂志的副主编,成为该杂志创刊70年来担任此职的第一位中国人。   Clinical Rheumatology创建于1945年,在风湿病领域具有重要影响力,目前是国际抗风湿病联盟(ILAR)的官方杂志。   Clinical Rheumatology旨在涵盖所有在临床和实验研究的现代趋势



日前,北京大学人民医院栗占国教授被聘Clinical Rheumatology杂志的副主编,成为该杂志创刊70年来担任此职的第一位中国人。
 
Clinical Rheumatology创建于1945年,在风湿病领域具有重要影响力,目前是国际抗风湿病联盟(ILAR)的官方杂志。
 
Clinical Rheumatology旨在涵盖所有在临床和实验研究的现代趋势以及评价炎症、免疫、代谢、遗传和退行性软、硬结缔组织疾病的诊断和治疗程序。覆盖了各类风湿免疫病及其同肾病、血液病、皮肤病等交叉学科的基础及临床研究。
栗占国教授目前担任国际风湿病联盟(ILAR)主席、亚太风湿病联盟(APLAR)主席,同时担任Int J Rheumatic Diseases副主编,以及Nature Reviews Rheumatology、Current Opinion Rheumatology、Ann Rheum Dis、Rheumatology和Clin and Exp Rheumatology等国际性杂志的编委。
 
栗教授受聘Clinical Rheumatology副主编,将进一步提升了我国在该领域的国际影响力,促进了我国风湿免疫病学科发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2041772, encodeId=76e82041e7216, content=<a href='/topic/show?id=96372910100' target=_blank style='color:#2F92EE;'>#免疫病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29101, encryptionId=96372910100, topicName=免疫病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Aug 23 18:01:00 CST 2014, time=2014-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797282, encodeId=9d641e97282c1, content=<a href='/topic/show?id=c75822682d8' target=_blank style='color:#2F92EE;'>#临床免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22682, encryptionId=c75822682d8, topicName=临床免疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sun Nov 30 09:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062492, encodeId=8ce12062492fa, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Dec 19 03:01:00 CST 2014, time=2014-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507607, encodeId=17f4150e60713, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Thu Jan 30 03:01:00 CST 2014, time=2014-01-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2041772, encodeId=76e82041e7216, content=<a href='/topic/show?id=96372910100' target=_blank style='color:#2F92EE;'>#免疫病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29101, encryptionId=96372910100, topicName=免疫病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Aug 23 18:01:00 CST 2014, time=2014-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797282, encodeId=9d641e97282c1, content=<a href='/topic/show?id=c75822682d8' target=_blank style='color:#2F92EE;'>#临床免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22682, encryptionId=c75822682d8, topicName=临床免疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sun Nov 30 09:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062492, encodeId=8ce12062492fa, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Dec 19 03:01:00 CST 2014, time=2014-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507607, encodeId=17f4150e60713, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Thu Jan 30 03:01:00 CST 2014, time=2014-01-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2041772, encodeId=76e82041e7216, content=<a href='/topic/show?id=96372910100' target=_blank style='color:#2F92EE;'>#免疫病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29101, encryptionId=96372910100, topicName=免疫病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Aug 23 18:01:00 CST 2014, time=2014-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797282, encodeId=9d641e97282c1, content=<a href='/topic/show?id=c75822682d8' target=_blank style='color:#2F92EE;'>#临床免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22682, encryptionId=c75822682d8, topicName=临床免疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sun Nov 30 09:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062492, encodeId=8ce12062492fa, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Dec 19 03:01:00 CST 2014, time=2014-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507607, encodeId=17f4150e60713, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Thu Jan 30 03:01:00 CST 2014, time=2014-01-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2041772, encodeId=76e82041e7216, content=<a href='/topic/show?id=96372910100' target=_blank style='color:#2F92EE;'>#免疫病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29101, encryptionId=96372910100, topicName=免疫病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sat Aug 23 18:01:00 CST 2014, time=2014-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797282, encodeId=9d641e97282c1, content=<a href='/topic/show?id=c75822682d8' target=_blank style='color:#2F92EE;'>#临床免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22682, encryptionId=c75822682d8, topicName=临床免疫)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Sun Nov 30 09:01:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062492, encodeId=8ce12062492fa, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Fri Dec 19 03:01:00 CST 2014, time=2014-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507607, encodeId=17f4150e60713, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Thu Jan 30 03:01:00 CST 2014, time=2014-01-30, status=1, ipAttribution=)]
    2014-01-30 zll0628
Baidu
map
Baidu
map
Baidu
map